
A biomedical engineer researching right ventricular function and pulmonary vascular disease. Opinions are mine. @rrvdpool@med-mastodon
Columbus, OH
Joined January 2017
- Tweets4.3K
- Following916
- Followers1.4K
- Likes27K
Rebecca Vanderpool, PhD retweeted
👋Don't forget to tag us at @ats_pc about all the #PH #PVD #PERT action while you're at #CHEST2026! We're all one community! 🫁🫀🌎 @accpchest @CHESTPulmCardio @atsearlycareer
Rebecca Vanderpool, PhD retweeted
Friend: “For people who fear snakes, why travel to Arizona for #CHEST2026?
Me: “To lose the fear of the yellow snake..”
If snakes make you uncomfortable, especially yellow ones, #CHEST2026 may be your chance to finally “cure” that fear, courtesy of @CHESTPulmCardio and @accpchest
We have put together an outstanding session on pulmonary artery catheterization and pulmonary hypertension:
Pulmonary Hypertension Hemodynamics in the Wild West: Follow the Yellow Snake Trail
🌵🏜️🐍
Join us Monday, October 19, 4:30 PM, at the 📍 Phoenix Convention Center, North Building, Room 122 B
See the attached flyer for details, or follow the link below for the full session information ⬇️
events.rdmobile.com/Sessions…
#EmoryBuck
@MeenakshiSridh4
#AdrianoTonelli
@ATS_PC
@PHAssociation
@PVRI
@ALATorax
Rebecca Vanderpool, PhD retweeted
Attending #CHEST2026 and interested in cardiac and pulmonary vascular disease?
See the entire list of PVD/CV sessions in one place 👇
Curated guide to pulmonary hypertension, pulmonary embolism, cardiovascular and cardiac ICU content, research activities, and other key CV and PVD-focused sessions.
Many thanks to our stellar PVD Section fellows,
#Romina Gomez and #Laura Saldivar, for compiling this valuable resource on behalf of @accpchest and the @CHESTPulmCardio Network
🌵 🌵 🌵 🌵
#CHEST2026 Phoenix, AZ October 18-21, 2026
@ATS_PC
@PHAssociation
@PVRI
@ALATorax
Rebecca Vanderpool, PhD retweeted
What an awesome resource for all the #CHEST2026 attendees! 👇👀🗓️
Attending #CHEST2026 and interested in cardiac and pulmonary vascular disease?
See the entire list of PVD/CV sessions in one place 👇
Curated guide to pulmonary hypertension, pulmonary embolism, cardiovascular and cardiac ICU content, research activities, and other key CV and PVD-focused sessions.
Many thanks to our stellar PVD Section fellows,
#Romina Gomez and #Laura Saldivar, for compiling this valuable resource on behalf of @accpchest and the @CHESTPulmCardio Network
🌵 🌵 🌵 🌵
#CHEST2026 Phoenix, AZ October 18-21, 2026
@ATS_PC
@PHAssociation
@PVRI
@ALATorax
Rebecca Vanderpool, PhD retweeted
How are you identifying post-PE phenotypes? This study's validation of the SEARCH algorithm offers clinicians a straightforward method to diagnose post-PE conditions that are rarely distinguished clinically. @ERSpublications buff.ly/7UmKuUj
Rebecca Vanderpool, PhD retweeted
New #PCTweetorials: PH Patient Perspectives 🫁 Diagnosis can take years, and fear, uncertainty, and treatment burden are as central to patients' stories as PVR and 6MWD. Time we listened — reading list below 👇 #PHAware #PulmonaryHypertension #MedEd
Rebecca Vanderpool, PhD retweeted
Sex-specific physiology influences disease progression and prognostic assessment in heart failure. Are there sex-based differences in indices of RV and pulmonary vascular function in these patients? Read more from @JAHA_AHA here buff.ly/tITNGCj
Rebecca Vanderpool, PhD retweeted
🚨 Journal Club Alert 🚨 Role of Forkhead box F1 in the Pathobiology of Pulmonary Arterial Hypertension, featuring Jose Gomez-Arroyo MD, Chris R. Rhodes PhD, Sue Gu MD.
📅 When: Thursday, October 1, 3-4 pm EST
🔗 Register here: buff.ly/XLH3OfI
Rebecca Vanderpool, PhD retweeted
Upcoming Journal Club!!! Join us to get involved with the discussion on new findings in pulmonary hypertension!!
When: October 1st, 3:00 PM EST
Register: nam12.safelinks.protection.o…
Rebecca Vanderpool, PhD retweeted
Rapid PHire question!
Which factors play a major role in PH-ILD prognosis?
Age? PVR? FVC? 🤔
Take a guess in the comments, then check out the full article below to see if you were right! 👇
publications.ersnet.org/cont…
Rebecca Vanderpool, PhD retweeted
Want to see what ATS assembly events are on the horizon? Bookmark this link and mark your calendars today ➡️ buff.ly/D5IGvKb
Rebecca Vanderpool, PhD retweeted
Beat the midweek blues with some early career inspiration 🤩 Meet Dr. Holtz:
Rebecca Vanderpool, PhD retweeted
Check out the newest @ATS_PC ECP Highlight!
Rebecca Vanderpool, PhD retweeted
Has a colleague made outstanding contributions to pulmonary disease, critical care, and sleep health? Nominate them for an ⭐️🏆️ ATS Respiratory Health Award 🏆️ ⭐️ by Sept 30! Learn more about each award and submit your nomination here: buff.ly/IauhUSN
Rebecca Vanderpool, PhD retweeted
We are excited to hire a postdoc for our growing research program at the Phoenix children’s research institute and the university of arizona! Join our team to work on novel mechanisms in pulmonary vascular disease! arizona.csod.com/ux/ats/care…
@ATS_PC
Rebecca Vanderpool, PhD retweeted
Please register to join us for our next webinar: Navigating Early-Career Funding: A Conversation with NHLBI Program Officers.
Register at: heart.zoom.us/webinar/regist…
Rebecca Vanderpool, PhD retweeted
Join us this week for our Pathways to Progress series with Carter L. Alleman, JD, CAE and Marah Wahbeh, PhD for their conversation on “Science Advocacy – How to Engage with Policy Makers as a Scientist”
in 170 DHLRI from 1p-2p on Friday, September 4th

ALT Dorothy M. Davis Heart and Lung Research Institute Pathways to Progress “Science Advocacy – How to Engage with Policy Makers as a Scientist” Friday, September 4, 2026 1:00pm - 2:00pm 170 DHLRI Carter L. Alleman, JD, CAE Director of Government Affairs and Science Policy at the American Society for Pharmacology and Experimental Therapeutics (ASPET) Marah Wahbeh, PhD Senior Manager of Government Affairs and Science Policy at the American Society for Pharmacology and Experimental Therapeutics (ASPET)
Rebecca Vanderpool, PhD retweeted
Best of Clinical ATS-PC Abstracts 2026
11:00 AM ET
Join our @ATS_PC as they explore the scientific significance /potential clinical impact of four abstracts presented at #ATS2026 !
Register here: shorturl.at/MgBEZ
Rebecca Vanderpool, PhD retweeted
Deeply grateful to the collaborators who brought physiology, engineering and computational biology in PH-HFpEF.
Moving beyond PVR to build a patient-specific map of where disease lives across the heart–pulmonary circulation. ahajournals.org/doi/full/10.…
@uw_medicine @UWCVRC @CircHF
Rebecca Vanderpool, PhD retweeted
What causes hypoxemia in pulmonary arteriovenous malformations? Here is a commentary by Dr. Naeije in this month's issue of the AJRCCM: academic.oup.com/ajrccm/arti…




















